ezogabine has been researched along with Convulsive Generalized Seizure Disorder in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bleakley, LE; McKenzie, CE; Reid, CA | 1 |
| Kelly, M; Knight, D; Mahida, S; Olson, HE; Poduri, A | 1 |
| Biton, V; DeRossett, S; Nohria, V; Partiot, A; Porter, RJ; Rosenfeld, WE; Sachdeo, R; Tompson, D | 1 |
1 trial(s) available for ezogabine and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Drug Administration Schedule; Drug Dosage Calculations; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Phenylenediamines; Research Design; Risk Assessment; Time Factors; Treatment Outcome; United States; Young Adult | 2014 |
2 other study(ies) available for ezogabine and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
Efficacy of antiseizure medication in a mouse model of HCN1 developmental and epileptic encephalopathy.
Topics: Animals; Anticonvulsants; Epilepsy; Epilepsy, Generalized; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Lamotrigine; Mice; Potassium Channels; Seizures; Valproic Acid | 2023 |
Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy.
Topics: Child, Preschool; Epilepsy; Epilepsy, Generalized; Humans; Infant; KCNQ2 Potassium Channel; Mutation; Retrospective Studies; Seizures | 2023 |